Five Stocks To Buy According To Top Biotech-Focused Funds
Biotechnology is a very interesting industry to invest in, but also very complex. If you are looking for stocks that are most likely to see their value......(read more)
Posts Tagged ‘Orbimed Advisors’
13D Filing: OrbiMed Advisors and Adaptimmune Therapeutics PLC – ADR (ADAP)
Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADAP): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors......(read more)
13D Filing: OrbiMed Advisors and Corvus Pharmaceuticals Inc (CRVS)
Corvus Pharmaceuticals Inc (NASDAQ:CRVS): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest......(read more)
13D Filing: OrbiMed Advisors and Viewray Inc. (VRAY)
Viewray Inc. (NASDAQ:VRAY): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest holdings and......(read more)
13D Filing: OrbiMed Advisors and Pieris Pharmaceuticals Inc. (PIRS)
Pieris Pharmaceuticals Inc. (NYSE:PIRS): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest......(read more)
13D Filing: OrbiMed Advisors and Nabriva Therapeutics PLC – ADR (NBRV)
Nabriva Therapeutics PLC – ADR (NASDAQ:NBRV): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’......(read more)
13D Filing: OrbiMed Advisors and Pieris Pharmaceuticals Inc. (PIRS)
Pieris Pharmaceuticals Inc. (NYSE:PIRS): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest......(read more)
13D Filing: OrbiMed Advisors and Alpine Immune Sciences Inc. (ALPN)
Alpine Immune Sciences Inc. (NASDAQ:ALPN): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest......(read more)
13D Filing: OrbiMed Advisors and Clementia Pharmaceuticals Inc (CMTA)
Clementia Pharmaceuticals Inc (NASDAQ:CMTA): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest......(read more)
13D Filing: OrbiMed Advisors and Xtant Medical Holdings Inc. (XTNT)
Xtant Medical Holdings Inc. (OTCMKTS:XTNT): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest......(read more)
13D Filing: OrbiMed Advisors and Pieris Pharmaceuticals Inc. (PIRS)
Pieris Pharmaceuticals Inc. (NYSE:PIRS): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest......(read more)
13D Filing: OrbiMed Advisors and Scpharmaceuticals Inc (SCPH)
Scpharmaceuticals Inc (NASDAQ:SCPH): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest holdings......(read more)
13D Filing: OrbiMed Advisors and Arsanis Inc (ASNS)
Arsanis Inc (NASDAQ:ASNS): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest holdings and filings......(read more)
13D Filing: OrbiMed Advisors and Loxo Oncology Inc. (LOXO)
Loxo Oncology Inc. (NASDAQ:LOXO): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest holdings......(read more)
13D Filing: OrbiMed Advisors and Intellia Therapeutics Inc (NTLA)
Intellia Therapeutics Inc (NASDAQ:NTLA): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest......(read more)
13D Filing: OrbiMed Advisors and Viewray Inc (VRAY)
Viewray Inc (NASDAQ:VRAY): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest holdings and filings......(read more)
13D Filing: OrbiMed Advisors and Rhythm Pharmaceuticals Inc (RYTM)
Rhythm Pharmaceuticals Inc (NASDAQ:RYTM): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest......(read more)
13D Filing: OrbiMed Advisors and Roka Bioscience Inc. (ROKA)
Roka Bioscience Inc. (NASDAQ:ROKA): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest holdings......(read more)
13D Filing: OrbiMed Advisors and Roka Bioscience Inc. (ROKA)
Roka Bioscience Inc. (NASDAQ:ROKA): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest holdings......(read more)
13D Filing: OrbiMed Advisors and Roka Bioscience Inc. (ROKA)
Roka Bioscience Inc. (ROKA): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest holdings and......(read more)
13D Filing: OrbiMed Advisors and Synlogic Inc. (SYBX)
Synlogic Inc. (NASDAQ:SYBX): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest holdings and......(read more)
13D Filing: OrbiMed Advisors and Clementia Pharmaceuticals Inc (CMTA)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 12 – SEC Filing UNITED STATESSECURITIES AND EXCHANGE......(read more)
13D Filing: OrbiMed Advisors and Roka Bioscience Inc. (ROKA)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 11 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)
13D Filing: OrbiMed Advisors and Selecta Biosciences Inc (SELB)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 12 – SEC Filing UNITED STATESSECURITIES AND EXCHANGE......(read more)
13D Filing: OrbiMed Advisors and Clementia Pharmaceuticals Inc (CMTA)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 14 – SEC Filing UNITED STATESSECURITIES AND EXCHANGE......(read more)
13D Filing: OrbiMed Advisors and Viewray Inc (VRAY)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 12 – SEC Filing UNITED STATESSECURITIES AND EXCHANGE......(read more)
13D Filing: OrbiMed Advisors and Alpine Immune Sciences Inc. (ALPN)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 10 – SEC Filing UNITED STATESSECURITIES AND EXCHANGE......(read more)
13D Filing: OrbiMed Advisors and Otonomy Inc. (OTIC)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 11 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)
13D Filing: OrbiMed Advisors and Ascendis Pharma A/S (ASND)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 14 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)
13D Filing: OrbiMed Advisors and Verona Pharma PLC (VRNA)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 12 – SEC Filing UNITED STATESSECURITIES AND EXCHANGE......(read more)
13D Filing: OrbiMed Advisors and Steadymed Ltd. (STDY)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 15 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)
13D Filing: OrbiMed Advisors and Viewray Inc. (VRAY)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 12 – SEC Filing UNITED STATESSECURITIES AND EXCHANGE......(read more)
Affimed N.V. (AFMD): OrbiMed Advisors Cuts Its Position
A freshly-amended 13D filing with the US SEC showed that Sam Isaly’s OrbiMed Advisors has sold some of its shares of Affimed N.V. (NASDAQ:AFMD), hence......(read more)
Steadymed Ltd. (STDY): OrbiMed Advisors Reports Large New Stake
Sam Isaly’s OrbiMed Advisors recently filed a Form 13D with the Securities and Exchange Commission in which reported the acquisition of 3.07 million......(read more)
Loxo Oncology Inc. (LOXO): OrbiMed Advisors Reports Percentage of Ownership Change
Samuel Isaly’s OrbiMed Advisors recently filed a 13D filing with the SEC in which it reported owning 2.18 million common shares of Loxo Oncology Inc......(read more)
Cynapsus Therapeutics Inc. (CYNA): OrbiMed Advisors Adds To Its Stake
According to a recent 13G filing with the US Securities and Exchange Commission Sam Isaly’s Orbimed Advisors has increased its stake in Cynapsus Therapeutics......(read more)
Selecta Biosciences Inc (SELB): OrbiMed Advisors Reports New Stake
Samuel Isaly’s Orbimed Advisors recently filed a Form 13D with the Securities and Exchange Commission, in which it reported a new stake in Selecta Biosciences......(read more)
Ascendis Pharma (ASND): OrbiMed Advisors Adds More Shares
Samuel Isaly just cannot get enough of Ascendis Pharma A/S (NASDAQ:ASND). According to an amended filing with the Securities and Exchange Commission,......(read more)
OrbiMed Advisors Buys Some More Ascendis Pharma (ASND) Shares
Samuel Isaly‘s OrbiMed Advisors has stepped up its interest in Ascendis Pharma A/S (NASDAQ:ASND) as reported in a recently-amended filing with......(read more)
Affimed NV (AFMD): Samuel Isaly Unloads Shares of Sinking Stock
Affimed NV (NASDAQ:AFMD) is the subject of a 13D filing from Samuel Isaly‘s OrbiMed Advisors, which shows that the investment firm has sold off......(read more)
A Look At Three Activist Moves By Several Elite Hedge Funds
According to the Schulte, Roth & Zabel’s Activist Investing 2015 Annual Review, 344 companies were targeted by activist investors in 2014, as compared......(read more)
Two Healthcare-Focused Funds Buy More Shares Of 2 Promising Companies, While Activist Cashes Out Of IT Company
You don’t necessarily need millions of dollars to invest like an activist investor such as Carl Icahn or Bill Ackman. Extensive research has concluded......(read more)
Hedge Fund Sentiment Has This to Say About These Moves on 3 Healthcare Stocks
It is easy to imagine that hedge funds would not reveal their equity positions if it were not for reporting requirements enforced by the Securities......(read more)
OrbiMed Advisors Piles On This Biotech; Should You Follow This Healthcare-Focused Firm?
It is commonly known that most hedge fund investors reveal their positions through 13F quarterly filings, but 13D filings tend to provide more insights......(read more)
These Two Healthcare Stocks Receive A Vote Of Confidence From Elite Hedge Fund Managers
As U.S equities have plummeted on global-growth worries, confident hedge funds and other investors have started piling up more shares of companies that......(read more)
Samuel Isaly’s New Healthcare Positions: Community Health Systems (CYH), Glaukos Corp (GKOS), More
Samuel Isaly’s OrbiMed Advisors is a healthcare fund with $15 billion worth of assets under management. The investment advisory firm has experience......(read more)
Aisling Capital and OrbiMed Advisors See Value in This Canadian Pharmaceutical Company, Disclosing New Positions
Dennis Purcell’s Aisling Capital and Samuel Isaly’s OrbiMed Advisors have initiated new positions in Cynapsus Therapeutics Inc (NASDAQ:CYNA). In new......(read more)
Samuel Isaly’s OrbiMed Advisors Discloses Large Stake in Glaukos Corp (GKOS) After Its IPO
Glaukos Corp (NYSE:GKOS) is an $870 million developer of products for the treatment of glaucoma, which conducted its IPO last week with 6.90 million shares......(read more)
Ariad Pharmaceuticals, Inc. (ARIA), Amgen, Inc. (AMGN): How Sarissa Capital’s Top Picks Beat the Market
Headquartered in Connecticut, Sarissa Capital Management was founded by Alexander J. Denner in 2012. Prior to this, Mr. Denner worked as a portfolio manager......(read more)
Esperion Therapeutics Inc (ESPR), Intercept Pharmaceuticals Inc (ICPT): Visium and OrbiMed’s Recent Activity in Biotech
Stocks in the biotechnology industry have been very active as of late, with companies’ shares registering significant gains. The industry jumped......(read more)
